Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
14 studies found for:    "Brugada syndrome" OR "Sudden unexpected nocturnal death syndrome" OR "Sudden unexplained death syndrome"
Show Display Options
Rank Status Study
1 Recruiting Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Conditions: Brugada Syndrome;   Arrhythmogenic Right Ventricular Cardiomyopathy
Intervention: Drug: flecainide iv
2 Unknown  DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome
Condition: Brugada Syndrome
Interventions: Drug: 3,4-Di-amino-Pyridine;   Drug: placebo
3 Terminated Hydroquinidine Versus Placebo in Patients With Brugada Syndrome
Condition: Brugada Syndrome
Interventions: Drug: hydroquinidine;   Drug: placebo (sugar)
4 Recruiting Brugada Syndrome: A New Treatment Approach Driven by Clinical Experience
Condition: Brugada Syndrome
Interventions: Procedure: Mapping;   Drug: Flecainide; ajmaline;   Procedure: Radiofrequency ablation;   Procedure: BrS Functional Substrate Re-mapping
5 Completed AnalyST & Brugada Syndrome - Feasibility Study
Condition: Brugada Syndrome
Intervention: Device: ECG continuous recording (Analyze ST)
6 Not yet recruiting Ablation in Brugada Syndrome for the Prevention of VF
Condition: Brugada Syndrome
Intervention: Procedure: Catheter Ablation
7 Enrolling by invitation Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias
Conditions: Inherited Cardiac Arrythmias;   Long QT Syndrome (LQTS);   Brugada Syndrome (BrS);   Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT);   Early Repolarization Syndrome (ERS);   Arrhythmogenic Cardiomyopathy (AC, ARVD/C);   Hypertrophic Cardiomyopathy (HCM);   Dilated Cardiomyopathy (DCM);   Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy);   Normal Control Subjects
8 Not yet recruiting The Response To Ajmaline Provocation in Healthy Subjects
Conditions: Brugada Syndrome;   Sudden Death
Intervention: Drug: Ajmaline
9 Recruiting Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients
Conditions: Brugada Syndrome;   S-ICD System (Implantable Defibrillator)
Intervention: Device: S-ICD System (implantable defibrillator)
10 Recruiting Empiric Quinidine for Asymptomatic Brugada Syndrome
Condition: Arrhythmia
Interventions: Drug: quinidine;   Drug: no therapy
11 Recruiting Worm Study: Modifier Genes in Sudden Cardiac Death
Conditions: Brugada Syndrome;   Long QT Syndrome 3
Interventions: Procedure: Dermal biopsy;   Behavioral: Gastro-intestinal questionnaire;   Genetic: Whole-exome sequencing
12 Completed Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
Conditions: Atrial Fibrillation;   Tachycardia, Ventricular;   Brugada Syndrome
Interventions: Drug: flecainide;   Drug: ajmaline;   Drug: procainamide
13 Recruiting Registry of Unexplained Cardiac Arrest
Conditions: Cardiac Arrest;   Long QT Syndrome;   Brugada Syndrome;   Catecholaminergi Polymorphic Ventricular Tachycardia;   Idiopathic VentricularFibrillation;   Early Repolarization Syndrome;   Arrhythmogenic Right Ventricular Cardiomyopathy
14 Unknown  Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases
Conditions: Long QT Syndrome;   Hypertrophic Cardiomyopathy;   Arrhythmogenic Right Ventricular Dysplasia

Indicates status has not been verified in more than two years